Advertisement

Loading...

Leap Therapeutics, Inc.

LPTX•NASDAQ
Healthcare
Biotechnology
$0.66
$-0.03(-3.91%)
U.S. Market opens in 0h 8m

Leap Therapeutics, Inc. (LPTX) Stock Overview

Explore Leap Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap27.2M
P/E Ratio9.01
EPS (TTM)$-1.58
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$0.43
3 Months$0.09
1 Year Target$1.43

LPTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Leap Therapeutics, Inc. (LPTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.43.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.01 and a market capitalization of 27.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.91%
5-Day Change
-11.64%
1-Month Change
5.21%
3-Month Change
-43.40%
6-Month Change
44.63%
Year-to-Date (YTD) Change
-41.89%
1-Year Change
115.21%
3-Year Change
-80.69%
5-Year Change
-96.54%
All-Time (Max) Change
-99.16%

Contact Information

https://www.leaptx.com
617 714 0360
47 Thorndike Street, Cambridge, MA, 02141

Company Facts

520 Employees
IPO DateJan 25, 2017
CountryUS
Actively Trading

Frequently Asked Questions